OBIO Orchestra BioMed
- 6.620
- +0.440+7.12%
Orchestra BioMed News
Orchestra BioMed Hldgs Analyst Ratings
H.C. Wainwright Initiates Orchestra BioMed(OBIO.US) With Buy Rating, Announces Target Price $14
Express News | Orchestra Biomed Holdings, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating and Target Price $14
Orchestra BioMed Reports Q2 Results
Piper Sandler Maintains Orchestra BioMed(OBIO.US) With Buy Rating, Maintains Target Price $15
Piper Sandler Remains a Buy on Orchestra BioMed Holdings (OBIO)
Buy Rating Affirmed for Orchestra BioMed on Strong Financials and Promising BackBeat CNT Developments
Express News | Orchestra Biomed Holdings Inc - May Offer and Sell Shares of Its Common Stock, Having Aggregate Offering Price of up to $100 Mln From Time to Time
Orchestra BioMed Holdings 2Q Loss/Shr 45c >OBIO
Orchestra BioMed Sees Expected Operating Cash Runway Into 2H of 2026 Based on Internal Forecast >OBIO
Earnings Flash (OBIO) ORCHESTRA BIOMED HOLDINGS Reports Q2 Revenue $0.8M
Express News | Orchestra Biomed Q2 Revenue USD 800 Thousand Vs. IBES Estimate USD 853.5 Thousand
Express News | Orchestra Biomed Q2 Net Income USD -16 Million
Express News | Orchestra Biomed Q2 EPS USD -0.45 Vs. IBES Estimate USD -0.39
Press Release: Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update
Orchestra BioMed | 10-Q: Q2 2024 Earnings Report
Orchestra BioMed Bolsters Board With Strategic Appointment
Express News | Orchestra Biomed Holdings Inc - Board Increased Size of Board From Seven to Eight Directors
Express News | Orchestra Biomed Announces Appointment of Cardiovascular Device Industry Expert John Mack to Board of Directors
Orchestra BioMed Holdings, Inc. (OBIO) Upgraded to Buy: Here's What You Should Know
Analysis
Price Target
No Data
